Gefitinib Versus Pemetrexed-Platinum Therapy in EGFR Activating Mutated Lung Cancer: Impact on Brain Metastasis

被引：0
|
作者：
Prabhash, K. [1 ]
Patil, V. [1 ]
Joshi, A. [1 ]
Noronha, V. [1 ]
Pande, N. [1 ]
Chandrasekaran, A. [2 ]
Mahajan, A. [2 ]
Janu, A. [2 ]
机构：
[1] Tata Mem Hosp, Dept Med Oncol, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
EGFR mutation; Brain metastasis; NSCLC;
D O I：
10.1016/j.jtho.2017.09.1922
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB059
引用
收藏
页码：S2384 / S2385
页数：2
相关论文
共 50 条
  • [1] Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer
    Noronha, Vanita
    Patil, Vijay Maruti
    Joshi, Amit
    Menon, Nandini
    Chougule, Anuradha
    Mahajan, Abhishek
    Janu, Amit
    Purandare, Nilendu
    Kumar, Rajiv
    More, Sucheta
    Goud, Supriya
    Kadam, Nandkumar
    Daware, Nilesh
    Bhattacharjee, Atanu
    Shah, Srushti
    Yadav, Akanksha
    Trivedi, Vaishakhi
    Behel, Vichitra
    Dutt, Amit
    Banavali, Shripad Dinanath
    Prabhash, Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 124 - +
  • [2] Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
    Ying Yuan
    Chunwen Tan
    Modan Li
    Hong Shen
    Xuefeng Fang
    Yinghong Hu
    Shenglin Ma
    [J]. World Journal of Surgical Oncology, 10
  • [3] Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
    Yuan, Ying
    Tan, Chunwen
    Li, Modan
    Shen, Hong
    Fang, Xuefeng
    Hu, Yinghong
    Ma, Shenglin
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [4] QTWiST Analysis to Compare the Benefit of Gefitinib Versus Pemetrexed Platinum for Patients with EGFR Mutated NSCLC
    Patil, V.
    Noronha, V.
    Joshi, A.
    Goel, A.
    Talreja, V.
    Kapoor, A.
    Kumar, R.
    Mahajan, A.
    Janu, A.
    Prabhash, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2231 - S2232
  • [5] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Kejun Liu
    Guanming Jiang
    Ailing Zhang
    Zhuanghua Li
    Jun Jia
    [J]. BMC Cancer, 20
  • [6] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Liu, Kejun
    Jiang, Guanming
    Zhang, Ailing
    Li, Zhuanghua
    Jia, Jun
    [J]. BMC CANCER, 2020, 20 (01)
  • [7] Frontline Systemic Therapy With Pemetrexed-Platinum in Nonsquamous Non-Small-Cell Lung Cancer With Asymptomatic Brain Metastases
    Alsidawi, Samer
    Chaudhary, Rekha
    Karim, Nagla A.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (02) : E111 - E120
  • [8] Quality of life in patients with EGFR-mutated lung cancer receiving gefitinib vs gefitinib plus pemetrexed and carboplatin chemotherapy
    Menon, N. S.
    Noronha, V.
    Chowdhury, O. Row
    Pawar, A. R.
    Patil, V. M.
    Singh, A. C.
    More, S.
    Goud, S.
    Yadav, A.
    Shah, M. J.
    Jobanputra, K. N.
    Shah, D. K.
    Prabhash, K.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1637 - S1637
  • [9] Effect of gefitinib an EGFR mutated lung cancer cell lines
    Salimi-Moosavi, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 234S - 234S
  • [10] Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Choughule, Anuradha Bharat
    Bhattacharjee, Atanu
    Kumar, Rajiv
    Goud, Supriya
    More, Sucheta
    Ramaswamy, Anant
    Karpe, Ashay
    Pande, Nikhil
    Chandrasekharan, Arun
    Goel, Alok
    Talreja, Vikas
    Mahajan, Abhishek
    Janu, Amit
    Purandare, Nilendu
    Prabhash, Kumar
    [J]. ESMO OPEN, 2017, 2 (01)
12345